Articles dans des revues avec comité de lecture (165)
  1. 138. Zouaoui Boudjeltia, K., Roumeguere, T., Delree, P., Moguilevsky, N., Ducobu, J., Vanhaeverbeek, M., & Wespes, E. (2007). Presence of LDL Modified by Myeloperoxidase in the Penis in Patients with Vascular Erectile Dysfunction: A Preliminary Study. European urology, 51(1), 262-269. doi:10.1016/j.eururo.2006.08.040
  2. 139. Zouaoui Boudjeltia, K., Legssyer, I., Van Antwerpen, P., Lema Kisoka, R., Babar, S., Moguilevsky, N., Delree, P., Ducobu, J., Remacle, C., Vanhaeverbeek, M., & Brohée, D. (2006). Triggering of inflammatory response by myeloperoxidase-oxidized LDL. Biochemistry and cell biology, 84(5), 805-812. doi:10.1139/o06-061
  3. 140. Prévot, P.-P., Adam, B., Zouaoui Boudjeltia, K., Brossard, M., Lins, L., Cauchie, P., Brasseur, R., Vanhaeverbeek, M., Vanhamme, L., & Godfroid, E. (2006). Anti-hemostatic effects of a serpin from the saliva of the tick Ixodes ricinus. The Journal of biological chemistry, 281(36), 26361-26369. doi:10.1074/jbc.M604197200
  4. 141. Zouaoui Boudjeltia, K., Gregoir, C., Guillaume, M., Remacle, C., Piro, P., Garbar, C., Ducobu, J., Moguilevsky, N., Vanhaeverbeek, M., Delree, P., & Brohée, D. (2006). Antigens and granularity of blood monocytes in relation to inflammatory markers and lipids in postmenopausal women. Maturitas, 55(2), 132-141. doi:10.1016/j.maturitas.2005.12.009
  5. 142. Van Antwerpen, P., Zouaoui Boudjeltia, K., Vaes, M., Babar, S., Madhoun, P., Moguilevsky, N., Vanhaeverbeek, M., Neve, J., & Ducobu, J. (2006). The pleiotropic effect of statins in haemodialysis patients is not the consequence of an inhibition of LDL oxidation by myeloperoxidase. Nephrology, dialysis, transplantation, 21(9), 2672-2674. doi:10.1093/ndt/gfl143
  6. 143. Cauchie, P., Cauchie, C., Zouaoui Boudjeltia, K., Carlier, E., Deschepper, N., Govaerts, D., Migaud-Fressart, M., Woodhams, B., & Brohée, D. (2006). Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital -- meaning of the ISTH score system, fibrin monomers, and lipoprotein-C-reactive protein complex formation. American journal of hematology, 81(6), 414-419. doi:10.1002/ajh.20597
  7. 144. Van Antwerpen, P., Legssyer, I., Zouaoui Boudjeltia, K., Babar, S., Moreau, P., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., & Neve, J. (2006). Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors. European journal of pharmacology, 537(1-3), 31-36. doi:10.1016/j.ejphar.2006.03.022
  8. 145. Zouaoui Boudjeltia, K., Guillaume, M., Henuzet, C., Delree, P., Cauchie, P., Remacle, C., Ducobu, J., Vanhaeverbeek, M., & Brohée, D. (2006). Fibrinolysis and cardiovascular risk factors: association with fibrinogen, lipids, and monocyte count. European journal of internal medicine, 17(2), 102-108. doi:10.1016/j.ejim.2005.11.002
  9. 146. Vereecken, P., Zouaoui Boudjeltia, K., Debray, C., Awada, A., Legssyer, I., Sales, F., Petein, M., Vanhaeverbeek, M., Ghanem, G. E., & Heenen, M. (2006). High serum galectin-3 in advanced melanoma: preliminary results. Clinical and experimental dermatology, 31(1), 105-109. doi:10.1111/j.1365-2230.2005.01992.x
  10. 147. Vereecken, P., Reynaert, S., Lalmand, M.-C., Zouaoui Boudjeltia, K., Heenen, M., Van Den Heule, B., & Petein, M. (2006). Decreased immunoreactive maspin expression in intermediate thickness and thick primary melanoma lesions. Journal of international medical research, 34(1), 52-57.
  11. 148. Zouaoui Boudjeltia, K., Van Meerhaeghe, A., Doumit, S., Guillaume, M., Cauchie, P., Brohée, D., Vanhaeverbeek, M., & Kerkhofs, M. (2006). Sleep apnoea-hypopnoea index is an independent predictor of high-sensitivity C-reactive protein elevation. Respiration, 73(2), 243-246. doi:10.1159/000090201
  12. 149. Van Antwerpen, P., Zouaoui Boudjeltia, K., Babar, S., Legssyer, I., Moreau, P., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., & Neve, J. (2005). Thiol-containing molecules interact with the myeloperoxidase/H 2O2/chloride system to inhibit LDL oxidation. Biochemical and biophysical research communications, 337(1), 82-88. doi:10.1016/j.bbrc.2005.09.013
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Suivant >>